UK cataract dataset audit reveals medications more likely to cause complications during surgery

Article

Clopidogrel and warfarin are associated with a significant increase in minor complications of sharp needle and subtenon?s cannula local anaesthesia but are not associated with sight-threatening complications, according to a study published online ahead of print by Eye.

Clopidogrel and warfarin are associated with a significant increase in minor complications of sharp needle and subtenon’s cannula local anaesthesia but are not associated with sight-threatening complications, according to a study published online ahead of print by Eye.

Robert Johnson from the Gloucestershire Eye Department, Cheltenham General Hospital, UK, and colleagues carried out a study to establish the prevalence of aspirin, dipyridamole, clopidogrel and warfarin use in patients undergoing cataract surgery and to compare local anaesthetic and intraoperative complication rates between users and non users. The Cataract National Dataset was extracted and anonymized on 48,862 operations at 12 National Health Service (NHS) Trusts using electronic patient records between 2001 and 2006.

In all, 28.1% of patients were taking aspirin, 5.1% warfarin, 1.9% clopidogrel and 1% dipyridamole. The incidence of any complication of a sharp needle or subtenon’s cannula local anaesthetic block was increased in patients taking clopidogrel (8%, p<0.0001) or warfarin (6.2%, p=0.0026) versus non-users. However, there was no increase in potentially sight-threatening complications. The incidence of subconjunctival haemorrhage was also increased in patients taking clopidogrel (4.4%, p<0.0001) or warfarin (3.7%, p<0.0001) versus non-users. The recording of operative complication was increased in those taking clopidogrel (7.3%, p=0.0002) versus non-users but the haemorrhagic operative complications of choroidal/suprachoroidal haemorrhage and hyphaema were not significantly increased.

The authors concluded that there is a significant increase in minor complications in cataract surgery patients taking clopidogrel and warfarin.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.